- Graduate
- Undergraduate
- Research
- News & events
- About us
- Student Commons
- Contact us
- Somers Research Group
- Faculty and Staff Resources
- Next Steps
- Incoming Students
- Spring 2020 Convocation
- The Roundtable
- Conversion Therapy Survey
- Fall 2020 Convocation
- RESET Team
- Spring 2021 Convocation
- Planetary Health Research Group
- The Breathe Project
Benedikt Fischer
Adjunct Professor, FHS
Benedikt Fischer
Adjunct Professor, FHS
Areas of interest
Psychoactive substance use, Interventions, Public Health
Biography
Benedikt Fischer, PhD (NPI) is Senior Scientist, Institute of Mental Health Policy Research (IMPHR), Centre for Addiction and Mental Health (CAMH), and Chair in Addiction Psychiatry & Professor in the Dept. of Psychiatry, with additional faculty appointments with the Institute of Medical Sciences and the Centre for Criminology & Sociolegal Studies, University of Toronto, and the Dept. of Psychiatry, Federal University of Sao Paulo, Brazil. He is also the NPI of the CIHR-funded Ontario CRISM Node Team.
Previously, he held a CIHR/PHAC Applied Public Health Research Chair and directed the Centre for Applied Research in Mental Health & Addictions (CARMHA), Faculty of Health Sciences ¶¡ÏãÔ°AV, Vancouver (2008 - 2015). Dr. Fischer's research interests primarily focus on the socio-behavioral epidemiology of illicit and psychotropic substance use and related health outcomes, including key comorbidities (e.g., mental health, pain, infectious diseases), as well as evidence-based interventions and policy in these areas. Much of his research focuses on marginalized/high-risk (e.g., youth, street-involved, correctional, indigenous) populations, with strong attention to knowledge translation and implementation. His research portfolio includes some 300 scientific publications, including as co-author of the international books: ‘Cannabis Policy: Moving Beyond Stalemate’ (2010) and 'Drug Policy and the Public Good' (2nd edition forthcoming). In 2016/17, he was Senior Science Advisor to Health Canada’s Cannabis Legalization & Regulation Office; previously he held science advisory positions with CIHR (Institute of Neurosciences, Mental Health and Addictions) and the Mental Health Commission of Canada (Science Advisory Board).